176 related articles for article (PubMed ID: 37011500)
21. Methodologies Related to Computational Models in View of Developing Anti-Alzheimer Drugs: An Overview.
Baheti K; Kale M
Curr Drug Discov Technol; 2019; 16(1):66-73. PubMed ID: 29663890
[TBL] [Abstract][Full Text] [Related]
22. Management of oxidative stress and other pathologies in Alzheimer's disease.
Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
[TBL] [Abstract][Full Text] [Related]
23. 1,3,4-Thiadiazole: A Versatile Pharmacophore of Medicinal Significance.
Bala M; Piplani P; Ankalgi A; Jain A; Chandel L
Med Chem; 2023; 19(8):730-756. PubMed ID: 36593699
[TBL] [Abstract][Full Text] [Related]
24. 1,3,4-Thiadiazoles: a potent multi targeted pharmacological scaffold.
Haider S; Alam MS; Hamid H
Eur J Med Chem; 2015 Mar; 92():156-77. PubMed ID: 25553540
[TBL] [Abstract][Full Text] [Related]
25. Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends.
Bachurin SO; Bovina EV; Ustyugov AA
Med Res Rev; 2017 Sep; 37(5):1186-1225. PubMed ID: 28084618
[TBL] [Abstract][Full Text] [Related]
26. Triazole derivatives as inhibitors of Alzheimer's disease: Current developments and structure-activity relationships.
Xu M; Peng Y; Zhu L; Wang S; Ji J; Rakesh KP
Eur J Med Chem; 2019 Oct; 180():656-672. PubMed ID: 31352246
[TBL] [Abstract][Full Text] [Related]
27. Design and evaluation of Nrf2 activators with 1,3,4-oxa/thiadiazole core as neuro-protective agents against oxidative stress in PC-12 cells.
Lin H; Qiao Y; Yang H; Li Q; Chen Y; Qu W; Liu W; Feng F; Sun H
Bioorg Med Chem Lett; 2020 Jan; 30(2):126853. PubMed ID: 31859162
[TBL] [Abstract][Full Text] [Related]
28. Imidazole: Multi-targeted Therapeutic Leads for the Management of Alzheimer's Disease.
Dhingra AK; Chopra B; Jain A; Chaudhary J
Mini Rev Med Chem; 2022; 22(10):1352-1373. PubMed ID: 34983347
[TBL] [Abstract][Full Text] [Related]
29. Current progresses of novel natural products and their derivatives/ analogs as anti-Alzheimer candidates: an update.
Fang L; Gou S; Fang X; Cheng L; Fleck C
Mini Rev Med Chem; 2013 May; 13(6):870-87. PubMed ID: 23305400
[TBL] [Abstract][Full Text] [Related]
30. Development of adamantane scaffold containing 1,3,4-thiadiazole derivatives: Design, synthesis, anti-proliferative activity and molecular docking study targeting EGFR.
Wassel MMS; Ammar YA; Elhag Ali GAM; Belal A; Mehany ABM; Ragab A
Bioorg Chem; 2021 May; 110():104794. PubMed ID: 33735711
[TBL] [Abstract][Full Text] [Related]
31. Topical Discoveries on Multi-Target Approach to Manage Alzheimer's Disease.
Batool A; Kamal MA; Rizvi SMD; Rashid S
Curr Drug Metab; 2018; 19(8):704-713. PubMed ID: 29512457
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and Evaluation of Antimicrobial Activity of 1, 3, 4-Thiadiazole Analogues for Potential Scaffold.
Sahu S; Sahu T; Kalyani G; Gidwani B
J Pharmacopuncture; 2021 Mar; 24(1):32-40. PubMed ID: 33833898
[TBL] [Abstract][Full Text] [Related]
33. Synthetic Compounds with 2-Amino-1,3,4-Thiadiazole Moiety Against Viral Infections.
Serban G
Molecules; 2020 Feb; 25(4):. PubMed ID: 32093125
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of novel steroidal curcumin derivatives as anti-Alzheimer's disease candidates: Evidences-based on in vivo study.
Elmegeed GA; Ahmed HH; Hashash MA; Abd-Elhalim MM; El-kady DS
Steroids; 2015 Sep; 101():78-89. PubMed ID: 26079653
[TBL] [Abstract][Full Text] [Related]
35. Rational drug design strategies for the development of promising multi-target directed indole hybrids as Anti-Alzheimer agents.
George N; Jawaid Akhtar M; Al Balushi KA; Alam Khan S
Bioorg Chem; 2022 Oct; 127():105941. PubMed ID: 35714473
[TBL] [Abstract][Full Text] [Related]
36. Exploring indole-based-thiadiazole derivatives as potent acetylcholinesterase and butyrylcholinesterase enzyme inhibitors.
Taha M; Rahim F; Uddin N; Khan IU; Iqbal N; Anouar EH; Salahuddin M; Farooq RK; Gollapalli M; Khan KM; Zafar A
Int J Biol Macromol; 2021 Oct; 188():1025-1036. PubMed ID: 34390751
[TBL] [Abstract][Full Text] [Related]
37. Discovery of Novel 2-Amino-5-(Substituted)-1,3,4-Thiadiazole Derivatives: New Utilities for Colon Cancer Treatment.
Raj V; Rai A; Singh AK; Keshari AK; Trivedi P; Ghosh B; Kumar U; Kumar D; Saha S
Anticancer Agents Med Chem; 2018; 18(5):719-738. PubMed ID: 28425852
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic potential of quinazoline derivatives for Alzheimer's disease: A comprehensive review.
Haghighijoo Z; Zamani L; Moosavi F; Emami S
Eur J Med Chem; 2022 Jan; 227():113949. PubMed ID: 34742016
[TBL] [Abstract][Full Text] [Related]
39. Hybrid molecules incorporating natural products: applications in cancer therapy, neurodegenerative disorders and beyond.
Decker M
Curr Med Chem; 2011; 18(10):1464-75. PubMed ID: 21428895
[TBL] [Abstract][Full Text] [Related]
40. Crystal structure of the Eg5 - K858 complex and implications for structure-based design of thiadiazole-containing inhibitors.
Talapatra SK; Tham CL; Guglielmi P; Cirilli R; Chandrasekaran B; Karpoormath R; Carradori S; Kozielski F
Eur J Med Chem; 2018 Aug; 156():641-651. PubMed ID: 30031975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
